Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Med Sci Monit ; 25: 5028-5035, 2019 Jul 07.
Artículo en Inglés | MEDLINE | ID: mdl-31280283

RESUMEN

BACKGROUND The aim of this study was to evaluate the effects of a new type of dietary fiber - high specific volume polysaccharide (HSVP) - on fecal properties, serum vasoactive intestinal peptide (VIP) concentration, intestinal flora count, and expression of the VIP-cAMP-PKA-AQP3 signaling pathway. MATERIAL AND METHODS Compound diphenoxylate was used in 48 healthy Wistar rats to establish a constipation model. Rats were divided into a normal control group, a constipation model group, an HSVP low-dose group, an HSVP medium-dose group, an HSVP high-dose group, and a fructose control group. We used colony count method, ELISA, WB, and RT-PCR to determine fecal moisture content, fecal hardness, fecal passage time, serum VIP concentration, number of intestinal bacteria, and VIP-cAMP-PKA-AQP3 signal pathway protein expression. RESULTS The constipation model was established successfully. HSVP (the medium dose was 10% and the high dose was 15%) improved fecal moisture content, reduced hardness, shortened fecal emptying time, increased intestinal bacteria, reduced serum VIP concentration, downregulated cAMP and PKAm RNA transcription, reduced protein expression, and reduced intestinal AQP3 expression. CONCLUSIONS HSVP improved constipation, increased the number of intestinal bacteria, and elevated expression of the VIP-cAMP-PKA-AQP3 signaling pathway. The mechanism of HSVP in regulating intestinal water metabolism in constipated rats may occur through the VIP-cAMP-PKA-AQP3 signaling pathway, and be closely related to changes in intestinal bacteria. The important role of the brain-gut-microbiome axis in the pathogenesis of constipation has been confirmed in this study.


Asunto(s)
Estreñimiento/tratamiento farmacológico , Fibras de la Dieta/uso terapéutico , Intestinos/efectos de los fármacos , Polisacáridos/uso terapéutico , Agua/metabolismo , Animales , Acuaporina 3/genética , Acuaporina 3/metabolismo , Estreñimiento/sangre , Estreñimiento/genética , Estreñimiento/fisiopatología , AMP Cíclico/metabolismo , Proteínas Quinasas Dependientes de AMP Cíclico/metabolismo , Fibras de la Dieta/farmacología , Heces , Microbioma Gastrointestinal/efectos de los fármacos , Tránsito Gastrointestinal/efectos de los fármacos , Dureza , Humedad , Polisacáridos/química , Polisacáridos/farmacología , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas Wistar , Transcripción Genética/efectos de los fármacos , Resultado del Tratamiento , Péptido Intestinal Vasoactivo/sangre , Péptido Intestinal Vasoactivo/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA